- New potential checkpoint inhibitors in cancer therapy2022 | Faculty of Medicine in Hradec Králové
- Treatment of a senior patient with cardiovascular comorbidities using checkpoint inhibitor therapy2022 | First Faculty of Medicine
- Insomnia in patients treated with checkpoint inhibitors for cancer: A meta-analysis2022 | First Faculty of Medicine
- Immune Checkpoint Inhibitor Myocarditis: Current Views on Diagnosis and Treatment2022 | First Faculty of Medicine
- Endocrine complications of modern cancer therapy2016 | Faculty of Medicine in Hradec Králové
- Identifying predictors of response to unresectable hepatocellular carcinoma treatment with checkpoint inhibitors remains a challenge for the future2021 | Publication without faculty affiliation
- COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma2022 | Third Faculty of Medicine
- Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors2020 | Faculty of Medicine in Pilsen
- The Abscopal Effect in the Era of Checkpoint Inhibitors2021 | First Faculty of Medicine
- Cancer, checkpoint inhibitors, and confusion2017 | Faculty of Science
- International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System2023 | Faculty of Medicine in Hradec Králové
- Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors' treatment: Spectrum of imaging appearances2018 | Second Faculty of Medicine, Third Faculty of Medicine
- Side Effects and Efficacy of Immunotherapy2020 | Faculty of Medicine in Pilsen
- The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma2023 | Faculty of Medicine in Pilsen
- Immunotherapy in the first line treatment of non-small cell lung cancer2020 | Faculty of Medicine in Pilsen
- Current possibilities of immunotherapy in the treatment of malignant melanoma2018 | Faculty of Medicine in Hradec Králové
- How, when, and why to evaluate the therapeutic response to checkpoint inhibitor immunotherapy in treating advanced non-small cell lung carcinoma2019 | First Faculty of Medicine
- Treatment of metastatic renal cell carcinoma in higher lines - patients after progression on TKI and immune checkpoint inhibitor2022 | First Faculty of Medicine
- Principles and mechanisms of side effects of modern immunooncological therapy2022 | First Faculty of Medicine
- Is anticancer imunotherapy break-trough in lung cancer therapy?2020 | First Faculty of Medicine
- Immunotherapeutic options for treatment of malignant melanoma2019 | First Faculty of Medicine
- Immunotherapy of Renal Cell Carcinoma2017 | First Faculty of Medicine
- Immunotherapy of lung cancer and basic principle of immune system acting2021 | Faculty of Medicine in Pilsen
- Gastrointestinal Toxicity of Immunotherapy2020 | First Faculty of Medicine
- New trends in immunotherapy of melanoma2020 | First Faculty of Medicine
- Immunotherapy in the treatment of lung cancer2017 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Current status of immunotherapy in the adjuvant treatment of invasive urothelial carcinoma2023 | Faculty of Medicine in Hradec Králové
- Adjuvant therapy of malignant melanoma: general and practical experience2021 | Faculty of Medicine in Hradec Králové
- Neurological complications of cancer immunotherapy2023 | Third Faculty of Medicine